StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Earnings

Vivos Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2025
$6.80M
+74.4% on a year earlier
EPS, Q3 FY2025
-$0.49
-$0.40 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Vivos Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2026ended Mar 31, 2026Apr 15, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Apr 15, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 19, 2025after the close$6.80M+74.4%-$0.49Release
Q2 FY2025ended Jun 30, 2025Aug 20, 2025after the close$3.80M-7.3%-$0.55Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close$3.00M-11.8%-$0.45Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024after the close$3.90M–-$0.40Release
Q2 FY2024ended Jun 30, 2024Aug 15, 2024after the close$4.10M+20.6%–Release
Q1 FY2024ended Mar 31, 2024May 15, 2024during market hours$3.40M-12.8%-$1.63Release
Q4 FY2023ended Dec 31, 2023Mar 29, 2024after the close$3.20M-20.0%–Release
Q2 FY2023ended Jun 30, 2023Aug 16, 2023after the close$3.40M–-$0.18Release
Q1 FY2023ended Mar 31, 2023Jun 8, 2023after the close$3.90M+11.4%-$0.07Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Vivos Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Vivos Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Vivos Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Update
  3. Update
  4. Update
  5. Update
  6. Update
  7. News
  8. Update
  9. Update
  10. Results
  11. News
  12. Results
  13. News
  14. News
  15. News

See a number that looks wrong?